Literature DB >> 25957290

Alterations of lung microbiota in a mouse model of LPS-induced lung injury.

Valeriy Poroyko1, Fanyong Meng2, Angelo Meliton2, Taras Afonyushkin2, Alexander Ulanov3, Ekaterina Semenyuk4, Omar Latif5, Vera Tesic6, Anna A Birukova2, Konstantin G Birukov2.   

Abstract

Acute lung injury (ALI) and the more severe acute respiratory distress syndrome are common responses to a variety of infectious and noninfectious insults. We used a mouse model of ALI induced by intratracheal administration of sterile bacterial wall lipopolysaccharide (LPS) to investigate the changes in innate lung microbiota and study microbial community reaction to lung inflammation and barrier dysfunction induced by endotoxin insult. One group of C57BL/6J mice received LPS via intratracheal injection (n = 6), and another received sterile water (n = 7). Bronchoalveolar lavage (BAL) was performed at 72 h after treatment. Bacterial DNA was extracted and used for qPCR and 16S rRNA gene-tag (V3-V4) sequencing (Illumina). The bacterial load in BAL from ALI mice was increased fivefold (P = 0.03). The community complexity remained unchanged (Simpson index, P = 0.7); the Shannon diversity index indicated the increase of community evenness in response to ALI (P = 0.07). Principal coordinate analysis and analysis of similarity (ANOSIM) test (P = 0.005) revealed a significant difference between microbiota of control and ALI groups. Bacteria from families Xanthomonadaceae and Brucellaceae increased their abundance in the ALI group as determined by Metastats test (P < 0.02). In concordance with the 16s-tag data, Stenotrohomonas maltophilia (Xanthomonadaceae) and Ochrobactrum anthropi (Brucellaceae) were isolated from lungs of mice from both groups. Metabolic profiling of BAL detected the presence of bacterial substrates suitable for both isolates. Additionally, microbiota from LPS-treated mice intensified IL-6-induced lung inflammation in naive mice. We conclude that the morbid transformation of ALI microbiota was attributed to the set of inborn opportunistic pathogens thriving in the environment of inflamed lung, rather than the external infectious agents.
Copyright © 2015 the American Physiological Society.

Entities:  

Keywords:  LPS; acute lung injury; metabolic profiling; microbiota

Mesh:

Substances:

Year:  2015        PMID: 25957290      PMCID: PMC4491514          DOI: 10.1152/ajplung.00061.2014

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  55 in total

1.  Early life antibiotic-driven changes in microbiota enhance susceptibility to allergic asthma.

Authors:  Shannon L Russell; Matthew J Gold; Martin Hartmann; Benjamin P Willing; Lisa Thorson; Marta Wlodarska; Navkiran Gill; Marie-Renée Blanchet; William W Mohn; Kelly M McNagny; Brett B Finlay
Journal:  EMBO Rep       Date:  2012-05-01       Impact factor: 8.807

2.  Competition, not cooperation, dominates interactions among culturable microbial species.

Authors:  Kevin R Foster; Thomas Bell
Journal:  Curr Biol       Date:  2012-09-06       Impact factor: 10.834

3.  Stimulation of Rho signaling by pathologic mechanical stretch is a "second hit" to Rho-independent lung injury induced by IL-6.

Authors:  Anna A Birukova; Yufeng Tian; Angelo Meliton; Alan Leff; Tinghuai Wu; Konstantin G Birukov
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-02-17       Impact factor: 5.464

4.  Regulatory T cell-mediated resolution of lung injury: identification of potential target genes via expression profiling.

Authors:  Neil R Aggarwal; Franco R D'Alessio; Kenji Tsushima; Venkataramana K Sidhaye; Christopher Cheadle; Dmitry N Grigoryev; Kathleen C Barnes; Landon S King
Journal:  Physiol Genomics       Date:  2009-12-22       Impact factor: 3.107

5.  Stenotrophomonas maltophilia infection in hematopoietic SCT recipients: high mortality due to pulmonary hemorrhage.

Authors:  K Tada; S Kurosawa; N Hiramoto; K Okinaka; N Ueno; Y Asakura; S-W Kim; T Yamashita; S-I Mori; Y Heike; A M Maeshima; R Tanosaki; K Tobinai; T Fukuda
Journal:  Bone Marrow Transplant       Date:  2012-05-28       Impact factor: 5.483

6.  Stenotrophomonas maltophilia strains replicate and persist in the murine lung, but to significantly different degrees.

Authors:  Ruella Rouf; Sara M Karaba; Jenny Dao; Nicholas P Cianciotto
Journal:  Microbiology (Reading)       Date:  2011-05-05       Impact factor: 2.777

Review 7.  Microbes and mucosal immune responses in asthma.

Authors:  Trevor T Hansel; Sebastian L Johnston; Peter J Openshaw
Journal:  Lancet       Date:  2013-03-09       Impact factor: 79.321

Review 8.  The dynamics of gut-associated microbial communities during inflammation.

Authors:  Sebastian E Winter; Christopher A Lopez; Andreas J Bäumler
Journal:  EMBO Rep       Date:  2013-03-12       Impact factor: 8.807

9.  Iloprost improves endothelial barrier function in lipopolysaccharide-induced lung injury.

Authors:  Anna A Birukova; Tinghuai Wu; Yufeng Tian; Angelo Meliton; Nicolene Sarich; Xinyong Tian; Alan Leff; Konstantin G Birukov
Journal:  Eur Respir J       Date:  2012-07-12       Impact factor: 16.671

10.  Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms.

Authors:  J Gregory Caporaso; Christian L Lauber; William A Walters; Donna Berg-Lyons; James Huntley; Noah Fierer; Sarah M Owens; Jason Betley; Louise Fraser; Markus Bauer; Niall Gormley; Jack A Gilbert; Geoff Smith; Rob Knight
Journal:  ISME J       Date:  2012-03-08       Impact factor: 10.302

View more
  37 in total

Review 1.  Homeostasis and its disruption in the lung microbiome.

Authors:  Robert P Dickson; John R Erb-Downward; Gary B Huffnagle
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-10-02       Impact factor: 5.464

Review 2.  The microbiome and critical illness.

Authors:  Robert P Dickson
Journal:  Lancet Respir Med       Date:  2015-12-12       Impact factor: 30.700

Review 3.  16S rDNA analysis of the effect of fecal microbiota transplantation on pulmonary and intestinal flora.

Authors:  Tianhao Liu; Zhongshan Yang; Xiaomei Zhang; Niping Han; Jiali Yuan; Yu Cheng
Journal:  3 Biotech       Date:  2017-10-12       Impact factor: 2.406

4.  The Lung Microbiome and ARDS. It Is Time to Broaden the Model.

Authors:  Robert P Dickson
Journal:  Am J Respir Crit Care Med       Date:  2018-03-01       Impact factor: 21.405

5.  Macrolides, inflammation and the lung microbiome: untangling the web of causality.

Authors:  Robert P Dickson; Alison Morris
Journal:  Thorax       Date:  2016-10-31       Impact factor: 9.139

Review 6.  Methods in Lung Microbiome Research.

Authors:  Sharon M Carney; Jose C Clemente; Michael J Cox; Robert P Dickson; Yvonne J Huang; Georgios D Kitsios; Kirsten M Kloepfer; Janice M Leung; Tricia D LeVan; Philip L Molyneaux; Bethany B Moore; David N O'Dwyer; Leopoldo N Segal; Stavros Garantziotis
Journal:  Am J Respir Cell Mol Biol       Date:  2020-03       Impact factor: 6.914

Review 7.  The impact of lung microbiota dysbiosis on inflammation.

Authors:  Daping Yang; Yingying Xing; Xinyang Song; Youcun Qian
Journal:  Immunology       Date:  2019-11-11       Impact factor: 7.397

8.  The Lung Microbiota of Healthy Mice Are Highly Variable, Cluster by Environment, and Reflect Variation in Baseline Lung Innate Immunity.

Authors:  Robert P Dickson; John R Erb-Downward; Nicole R Falkowski; Ellen M Hunter; Shanna L Ashley; Gary B Huffnagle
Journal:  Am J Respir Crit Care Med       Date:  2018-08-15       Impact factor: 21.405

9.  Development of a Stable Lung Microbiome in Healthy Neonatal Mice.

Authors:  Matea Kostric; Katrin Milger; Susanne Krauss-Etschmann; Marion Engel; Gisle Vestergaard; Michael Schloter; Anne Schöler
Journal:  Microb Ecol       Date:  2017-09-13       Impact factor: 4.552

10.  Enrichment of the lung microbiome with gut bacteria in sepsis and the acute respiratory distress syndrome.

Authors:  Robert P Dickson; Benjamin H Singer; Michael W Newstead; Nicole R Falkowski; John R Erb-Downward; Theodore J Standiford; Gary B Huffnagle
Journal:  Nat Microbiol       Date:  2016-07-18       Impact factor: 17.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.